Prevalence of statin utilization and adherence among privately insured subjects in the Commonwealth of Puerto Rico

Prevalence of statin utilization and adherence among privately insured subjects in the Commonwealth of Puerto Rico

BACKGROUND: Puerto Ricans are the Hispanic subgroup with the highest adjusted prevalence of statin-eligible patients. However, no study has described statin utilization and adherence among subjects living on the island of Puerto Rico. OBJECTIVES: To (a) estimate the prevalence of beneficiaries with...

Full description

Bibliographic Details
Main Authors: Hernández-Muñoz, J.J (Author), Kamdar, C.R (Author), Wong, E.S (Author)
Format: Article
Language:English
Published: Academy of Managed Care Pharmacy (AMCP) 2021
Subjects:
adult
Adult
aged
Aged
alpha glucosidase inhibitor
amlodipine plus atorvastatin
amylin derivative
antidiabetic agent
Article
diabetes mellitus
Diabetes Mellitus, Type 2
diabetic patient
dipeptidyl peptidase IV inhibitor
dopamine receptor stimulating agent
drug utilization
economics
ezetimibe plus simvastatin
female
Female
glucagon like peptide 1 receptor agonist
health insurance
human
Humans
hydroxymethylglutaryl coenzyme A reductase inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors
incretin
insulin derivative
insulin sensitizing agent
Insurance, Health
Longitudinal Studies
longitudinal study
major clinical study
male
Male
Medication Adherence
medication compliance
meglitinide
middle aged
Middle Aged
non insulin dependent diabetes mellitus
patient compliance
pharmacy (shop)
pharmacy benefit manager
prescription
prevalence
Prevalence
private health insurance
Puerto Rico
Retrospective Studies
retrospective study
sodium glucose cotransporter 2 inhibitor
sulfonylurea
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items